Sales Growth Soars to over 80% for 2016 NEWS – Bournemouth, UK: Solentim, the leader in Cell Line Development instrumentation, announce another record year of sales. “We have seen worldwide order values increase by over 80% year-on-year for calendar year 2016, and now nine out of the Top Ten Pharma have purchased Cell Metric for their […]
Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the Tecan Group since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, Tecan announced that Dr. Stefan Traeger, Head of […]
MORGANTOWN, W.Va. — Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) announced today that the Company has entered into a co-marketing agreement with MatTek Corporation (“MatTek”), which allows Protea to include MatTek’s human cell based in vitro tissue models with Protea’s proprietary molecular imaging services. “By combining the human tissue models with mass spectrometry imaging workflows, researchers will be able […]
CROMWELL, Conn. & WINDSOR, Conn.–Biological Industries USA, Inc. (BI‐USA) and Rainbow Scientific, Inc. announced today a co‐promotion and sales agreement that grants Rainbow Scientific both promotion and sales rights to BI-USA’s range of cytogenetic products to the clinical laboratory market. “Rainbow Scientific has been a leading distributor to hospital laboratories, medical reference laboratories, and clinical […]
SAN DIEGO & HERCULES, Calif.– Illumina, Inc. (NASDAQ:ILMN) and Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response. […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. Total revenue for the fourth quarter of 2016 is expected to be in the range of approximately $24.7 million to $25.2 million based on preliminary, unaudited financial data. At the midpoint of the […]
New fluorescence option enables specific applications in cell line development Bournemouth, UK – Solentim, the developer of instrumentation for cell line development, announced today that it has launched a major enhancement for its world leading verification of clonality platform, the Cell Metric®. This enhancement, which enables two channel fluorescence on the Cell Metric and Cell Metric […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
